세계의 기관지염 치료 시장 : 유형별, 치료법별, 약제 유형별, 투여 경로별, 유통 채널별, 지역별

Global bronchitis treatment market is estimated to be valued at USD 8.22 Bn in 2024 and is expected to reach USD 11.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.

Figure. Global Bronchitis Treatment Market Share (%), By Region 2024

Bronchitis is an inflammation of the bronchi or air passages that carry air to the lungs. It causes coughing, wheezing and shortness of breath. Global bronchitis treatment market can witness growth due to rising rates of respiratory illnesses. Increasing pollution levels, tobacco consumption and changing lifestyle habits across the world can offer market growth opportunities. Advancements in medicine have also expanded treatment options available to patients suffering from both acute and chronic bronchitis.

Market Dynamics:

Global bronchitis treatment market growth is driven by factors such as rising pollution levels, aging population and growing tobacco consumption. Increased carbon emissions have deteriorated air quality and more particulate matter in the air leads to higher incidences of respiratory infections. Furthermore, cigarettes and other tobacco products damage lung tissues over time and make people more susceptible to bronchitis. However, stringent regulations around tobacco products and higher health awareness can hamper the market growth. Adoption of digital health tools and remote monitoring devices can offer opportunity for telehealth services to manage bronchitis care more efficiently.

Key Features of the Study:

This report provides in-depth analysis of the global bronchitis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bronchitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, Sanofi Aventis, Boehringer Ingelheim, Astellas Pharma and Bayer

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

Global bronchitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchitis treatment market

Detailed Segmentation-

• By Type:
  • Acute Bronchitis
  • Chronic Bronchitis
  • By Treatment
  • Drugs
  • Oxygen Therapy
• By Drug Class
  • Anti-Inflammatory Drugs
  • Antibiotics
  • Bronchodilators
  • Mucolytic
• By Route of Administration
  • Oral
  • Parenteral
  • Inhalers/Nasal sprays
  • Others
• By Distribution Channel
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Novartis
  • Merck & Co.
  • Pfizer
  • Teva Pharmaceutical Industries
  • Sanofi
  • Roche
  • Johnson & Johnson
  • Mylan N.V.
  • Gilead Sciences
  • AbbVie
  • Bausch Health Companies
  • Hikma Pharmaceuticals
  • Amgen
  • Sumitomo Dainippon Pharma
  • Eli Lilly and Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bronchitis Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bronchitis Treatment Market, By Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Acute Bronchitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Chronic Bronchitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Bronchitis Treatment Market, By Treatment, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Oxygen Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Bronchitis Treatment Market, By Drug Class, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Anti-Inflammatory Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Antibiotics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Bronchodilators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Mucolytic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Bronchitis Treatment Market, By Route of Administration, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Inhalers/Nasal sprays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Bronchitis Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global Bronchitis Treatment Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
  • Boehringer Ingelheim
  • Novartis
  • Merck & Co.
  • Pfizer
  • Teva Pharmaceutical Industries
  • Sanofi
  • Roche
  • Johnson & Johnson
  • Mylan N.V.
  • Gilead Sciences
  • AbbVie
  • Bausch Health Companies
  • Hikma Pharmaceuticals
  • Amgen
  • Sumitomo Dainippon Pharma
  • Eli Lilly and Company

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact